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OBJECTIVE — We examined the relationships of visceral fat area (VFA), subcutaneous fat
area, and waist circumference, determined using computed tomography (CT), and BMI with
metabolic risk factors in a large Japanese population.
RESEARCH DESIGN AND METHODS — Study subjects comprised 6,292 men and
womenwhoparticipatedintheHitachiHealthStudyandreceivedCTexaminationsin2007and
2008.
RESULTS — Regarding the clustering of metabolic risk factors, the odds ratios (ORs) for the
VFAquintileswere1.0(ref.),2.4,3.4,5.0,and9.7formenand1.0(ref.),1.5,2.6,4.6,and10.0
for women (P  0.001 for trends in both sexes). For the highest quintiles, the OR for VFA was
1.5 to 2 times higher than those of the other anthropometric indexes in both sexes.
CONCLUSIONS — We demonstrated a superior performance of VFA to predict the clus-
tering of metabolic risk factors compared with other anthropometric indexes.
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M
etabolic syndrome (MS) has been
growing globally with the clusters
of obesity, high blood pressure,
impairedlipidmetabolism,andhypergly-
cemia. Individuals with MS have a higher
risk of cardiovascular disease and a sub-
sequent increase in disease mortality or
morbidity (1–3). For the diagnosis of MS,
waist circumference (WC) is almost al-
ways used as one of the criteria, and this
measure is typically used as a simpliﬁed
measure of the visceral fat area (VFA) (4–
7).Visceralfatisregardedasanendocrine
organ that secretes adipocytokines and
othervasoactivesubstancesthatcaninﬂu-
ence the risk of developing traits of MS
(8). A few studies have shown the impact
of visceral fat on MS and its components
inlarge-scaleepidemiologicalresearchef-
forts (9). The present study analyzed the
epidemiologicalimpactofVFAcompared
with that of subcutaneous fat area (SFA),
WC, and BMI against the clustering of
metabolic risk factors and its com-
ponents.
RESEARCH DESIGN AND
METHODS— Of 17,606 employees
and their spouses who, after more than
12 h of fasting, underwent a health exam-
ination in Hitachi, Ibaraki Prefecture, be-
tween 2007 and 2008, we analyzed data
for 6,292 subjects (5,606 men and 686
women),aged26to75years,whounder-
went a computed tomography (CT) ex-
amination, answered a questionnaire on
lifestyle and health, and did not have a
history of serious illness (cancer, cerebro-
vascular disease, or myocardial infarc-
tion). VFA, SFA, and WC were measured
using a CT scanner according to a proto-
coldescribedelsewhere(10).Thepresent
study was approved by the ethics com-
mittee of the National Center for Global
Health and Medicine. Written informed
consent was obtained from all subjects.
In this study, subjects with two or
more of the four risk factors (high blood
pressure, high triglyceride, low HDL cho-
lesterol, and hyperglycemia) deﬁned in
the criteria of the National Cholesterol
Education Program’s Adult Treatment
PanelIIIguidelinesin2005(6),exceptfor
WC,weredeﬁnedashavingtheclustering
of metabolic risk factors. Subjects cur-
rently receiving treatment for hyperlipid-
emia, hypertension, or diabetes were
deemed as having the respective risk fac-
tors, regardless of the biochemical values.
Wedividedthesubjectsintoquintiles
(Q1 to Q5) according to each anthropo-
metricvalueandcalculatedtheoddsratio
(OR) of the clustering of metabolic risk
factors and its components adjusted for
age, smoking habits, alcohol consump-
tion, and regular physical activity using a
logisticregressionanalysis,withQ1asthe
reference. All analyses were performed
using SPSS for Windows, Version 15.0
(SPSS, Chicago, IL).
RESULTS— The mean VFA was
123.7  51.2 cm
2 in men and 85.1 
45.2 cm
2 in women. The mean SFA was
134.8  56.6 cm
2 in men and 182.5 
72.9 cm
2 in women. The ratio of VFA to
SFA was 1:1 for men and 1:2 for
women. The mean WC was 86.4  8.3
cm in men and 83.2  9.2 cm in women.
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2 in
men and 23.0  3.3 kg/m
2 in women.
The prevalence of the clustering of meta-
bolic risk factors was 46.0% in men and
30.0% in women.
In Fig. 1, the ORs for the clustering of
metabolic risk factors are shown accord-
ing to each anthropometric index. The
OR was 1.5 to 2 times higher for the Q5
VFA category than for the other Q5 cate-
gories for both men and women. The OR
(95% CI) of the VFA quintiles were, re-
spectively, 1.0, 2.4 (2.0–2.9), 3.4 (2.8–
4.2), 5.0 (4.1–6.0), and 9.7 (8.0–11.9)
for men and 1.0, 1.5 (0.7–3.2), 2.6 (1.3–
5.3), 4.6 (2.3–9.1), and 10.0 (5.0–19.9)
for women (P  0.001 for trends in both
sexes). According to the SFA quintiles,
ORs were, respectively, 1.0, 1.8 (1.5–
2.2), 2.6 (2.2–3.1), 3.1 (2.6–3.7), and
4.8 (4.0–5.8) for men and 1.0, 1.3 (0.7–
2.5), 2.3 (1.3–4.3), 3.5 (1.9–6.4), and
4.5 (2.5–8.4) for women (P  0.001 for
trends in both sexes).
The OR for a high triglyceride level, a
low HDL level, high blood pressure, and
hyperglycemia increased with increasing
quintile categories of each anthropomet-
ricindex.TheOR(95%CI)oftheQ5VFA
category for a high triglyceride level was
9.0 (7.3–11.1) in men and for a low HDL
level was 7.1 (4.8–10.5) in men and 11.0
(4.0–30.1) in women, exhibiting ex-
tremely high ORs.
The slope for VFA is signiﬁcantly
steeper than those for SFA, WC, and BMI
on high triglyceride and on clustering of
metabolic risk factors (P  0.05) except
for the slope on the clustering of meta-
bolic risk factors in women.
CONCLUSIONS— In the present
study, a stronger association between an
increasing VFA and the clustering of met-
abolic risk factors and its components
than for an increasing SFA, WC, or BMI
was observed. Among metabolic risk fac-
tors,ahightriglyceridelevelinmenanda
low HDL cholesterol level in both men
and women showed particularly strong
associations with VFA.
BMI and WC are used clinically to
measureobesity,butdonotexactlyreﬂect
visceral adiposity. A previous report
showed that some individuals with a nor-
mal BMI and WC actually had an exces-
sive amount of visceral fat and metabolic
riskfactors(11).Inourstudy,theORsfor
the clustering of metabolic risk factors
were similar for BMI and WC in men, but
the OR for WC was lower than that for
BMI(whichwassimilartothatforSFA)in
women. The OR of VFA and SFA differed
according to sex. Furthermore, a stronger
correlation was observed between WC
and SFA than between WC and VFA. Fox
et al. (9) reported similar results. These
ﬁndings suggest that WC measurements
in women may have the same meaning as
SFA measurements, explaining the simi-
larity of the OR for the clustering of met-
abolic risk factors in WC and SFA.
The present study adds evidence to
support an important role for VFA in the
Figure 1—ORs for high triglyceride and the clustering of metabolic risk factors according to the quintiles (Q1–Q5) of VFA, SFA, WC, and BMI
adjusted for age, smoking habits (never, current, past), alcohol consumption (nondrinker, drinker consuming two go or less per day [a go is a
conventional unit of alcohol intake in Japan and contains 23 g of ethanol], or consuming more than two go per day), and regular ﬁtness habit
(yes/no).ThesymbolsaretheestimatedORsusingQ1asthereferencecategory.Thecurvesareﬁttedbythelogisticregressionmodels.Theslopefor
VFA is signiﬁcantly steeper than those for SFA, WC, and BMI on high triglyceride and on clustering of metabolic risk factors (P  0.05) except for
that on the clustering of metabolic risk factors in women. (A high-quality digital representation of this ﬁgure is available in the online issue.)
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tering in Japanese adults. Further studies
are needed to conﬁrm this association
prospectively and to examine the impact
of VFA on the risk of cardiovascular
disease.
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